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Abstract
Since 2003, more than 380 cases of H5N1 influenza virus infection of humans have been reported. Although the resultant
disease in these cases was often severe or fatal, transmission of avian influenza viruses between humans is rare. The precise
nature of the barrier blocking human-to-human spread is unknown. It is clear, however, that efficient human-to-human
transmission of an antigenically novel influenza virus would result in a pandemic. Influenza viruses with changes at amino
acids 627 or 701 of the PB2 protein have been isolated from human cases of highly pathogenic H5 and H7 avian influenza.
Herein, we have used the guinea pig model to test the contributions of PB2 627 and 701 to mammalian transmission. To
this end, viruses carrying mutations at these positions were generated in the A/Panama/2007/99 (H3N2) and A/Viet Nam/
1203/04 (H5N1) backgrounds. In the context of either rPan99 or rVN1203, mutation of lysine 627 to the avian consensus
residue glutamic acid was found to decrease transmission. Introduction of an asparagine at position 701, in conjunction
with the K627E mutation, resulted in a phenotype more similar to that of the parental strains, suggesting that this residue
can compensate for the lack of 627K in terms of increasing transmission in mammals. Thus, our data show that PB2 amino
acids 627 and 701 are determinants of mammalian inter-host transmission in diverse virus backgrounds.
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Introduction
Repeated introductions of avian H5N1 influenza viruses into
the human population have resulted in more than 380 reported
cases of severe disease since 2003. Greater than half of these cases
have been fatal, highlighting the extreme pathogenicity of H5N1
influenza in humans. Furthermore, high viral loads have been
detected in clinical specimens collected from infected patients [1].
Nevertheless, H5N1 influenza viruses do not transmit efficiently
from person-to-person. Prior to the 1997 and ongoing 2003
outbreaks of H5N1 zoonoses, it was generally assumed that an
influenza virus with the traits of efficient viral growth and
pathogenicity in a given host species would transmit between
individuals of that species. The phenotype of H5N1 viruses in
humans has changed that view: it is now clear that specific viral
factors are required to support inter-host transmission. The
consequences of human-to-human spread of H5N1 influenza
viruses would be of pandemic proportions; for this reason,
significant effort has been expended in recent years towards the
identification of molecular determinants of transmission. As a
result of these efforts, it has become clear that transmissibility
among humans is a complex and polygenic trait [2,3]. Affinity of
the viral hemagglutinin (HA) protein for a-2,6 linked sialic acid
residues has been shown to be necessary [4] but not sufficient [2,5]
to support transmission between ferrets. Due to its importance in
determining viral host range and pathogenicity, the viral
polymerase complex has also been suggested to play a role in
transmission [3,6], but this hypothesis has not been tested directly.
Additional viral proteins as well as host and environmental factors
[7,8] are also likely to impact the success of human-to-human
spread of influenza viruses.
Amino acid 627 of the PB2 protein is almost exclusively a lysine
in human influenza isolates and a glutamic acid in avian influenza
isolates. This residue was first recognized as a determinant of host
range in 1993 [9], and was later shown to contribute to the
temperature sensitivity of avian viral replication in mammalian
cells [10]. In particular, the introduction of a lysine at position 627
of an avian virus PB2 protein greatly improved replication of a
minigenome segment in cells incubated at 33uC [10]. This finding
has also been confirmed in the context of infected cell cultures: the
growth of A/Viet Nam/1204/04 virus (VN1204; H5N1) in
mammalian cell lines is improved at 33uC, but not 37uCo r4 1 uC,
by the single amino acid change, PB2 E627K. Furthermore,
rVN1204 possessing 627K was found to grow more efficiently in
the nasal turbinates of mice than the wild-type virus [6]. A recently
reported observation provides some insight into the mechanism
underlying the effects of the E to K change: the introduction of E
at 627 into the WSN PB2 appears to decrease its association with
the NP protein, in mammalian but not avian cells [11]. In addition
to affecting host range and tissue tropism, PB2 627K has also been
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H7N7 subtype influenza viruses in mammalian hosts [12–15].
Perhaps the most striking aspect of the polymorphism at PB2 627
is the rapidity with which lysine at this position arises when an
avian influenza virus infects either a mouse or a human. A single
passage in mice has been reported to be sufficient for an E627K
variant to dominate the resultant H5N1 virus population [6,16].
The presence of PB2 627K has furthermore been identified in
multiple human isolates of H5N1 viruses [1,17,18].
Similarly to E627K, a change of PB2 amino acid 701 from
aspartic acid to asparagine has been implicated in expanding the
host range of avian (or avian-like) H5N1 and H7N7 subtype
viruses to include mice [19,20] and humans [1]. In addition, an
asparagine at PB2 701 is a common feature of avian-like H3N2
swine viruses circulating in Europe. A mechanism has recently
been proposed to explain the contribution of D701N to improved
growth of a mouse adapted avian-like H7N7 virus, SC35M, in
mammalian cell culture: D701N appears to enhance the binding
of PB2 to importin a1 and correspondingly increase PB2 levels in
the nucleus in mammalian, but not avian, cells [21].
A potential correlation between the polymorphisms at PB2
positions 627 and 701 was observed in H5N1 viruses collected from
humans in 2004–2005. de Jong et al. reported that, among twelve
clinical isolates, eight possessed 627K while a distinct three viruses
carried 701N. The authors suggested that 701N may compensate
for the lack of 627K in the context of mammalian cells [1].
Herein, we have evaluated two hypotheses: i) PB2 627K
promotes the transmission of influenza viruses between mammals
through improved growth in the upper respiratory tract, and ii) an
asparagine at PB2 701 can functionally replace 627K in
supporting viral growth and transmission in mammals. We used
the guinea pig model to test the effects of polymorphisms at PB2
positions 627 and 701 on aerosol transmission of the recombinant
human H3N2 isolate, A/Panama/2007/99 (rPan99), which we
have previously shown to transmit with high efficiency [22], and
on contact transmission of the recombinant human H5N1 isolate,
A/Viet Nam/1203/04 (rVN1203). We show that rVN1203
transmits with moderate efficiency by the contact route in the
guinea pig model. Furthermore, the mutation K627E decreases
the transmission efficiency of both rPan99 and rVN1203 viruses.
Contrary to previous reports and to our first hypothesis, we did
not, however, observe a marked difference between the 627K and
627E containing viruses in terms of peak viral titers attained in vivo.
Our second hypothesis did prove correct in that combination of
glutamic acid at 627 with an aspartic acid to asparagine change at
position 701 rescues the phenotype of the 627E viruses: rPan99
virus with 627E+701N transmits with similar efficiency to the
parental rPan99 virus, while the rVN1203 627E 701N virus
transmits with higher efficiency than the wild-type strain. Our data
show that specific adaptations of the viral polymerase to the
mammalian host support the transmission of influenza viruses of
diverse lineage, revealing one viral trait that could contribute to
the making of a pandemic strain.
Results
Rescue and in vitro characterization of recombinant
viruses
Reverse genetics systems for Pan99 and VN1203 viruses were
used to generate recombinant viruses which encode the mutations
K627E alone or K627E and D701N combined, in their respective
PB2 segments. All four mutant viruses and the two recombinant
parental viruses were successfully recovered from cDNA transfec-
tion. Reverse transcription followed by PCR and sequencing of the
PB2 gene segment of each virus confirmed that the expected
sequence was present. As sequencing was only performed on the
PB2 segment, it cannot be formally excluded that random
mutation of the remaining segments may have contributed to
the phenotypes observed. The PB2 genotype of each virus is
summarized in Table 1.
To confirm that the three rVN1203 viruses possessed the
polybasic cleavage site associated with high pathogenicity in H5N1
influenza viruses, growth in the absence of exogenous trypsin was
assessed by plaque assay on MDCK cells. None of the viruses
required trypsin for plaque formation, in contrast to the
laboratory-adapted strain A/Puerto Rico/8/34 (data not shown).
A preliminary estimate of the fitness of each recombinant virus
was obtained by evaluating their plaque phenotypes on MDCK
cells. Since previous reports indicate that the polymorphism at
PB2 627 impacts viral growth at decreased temperature, plaque
assays were performed in duplicate and incubated at either 37uC
or 33uC. As seen in Figure 1A and 1B, at both 37uC and 33uC,
rPan99 produced the largest plaques of the rPan99 derived viruses.
The rPan99 PB2 627E virus formed slightly smaller plaques than
either wild-type or rPan99 627E 701N viruses (p,0.001 at 37uC;
p,0.001 relative to wild-type at 33uC, and p,0.01 relative to
rPan99 627E 701N at 33uC). The rPan99 virus encoding PB2
627E 701N produced plaques which were not significantly smaller
than rPan99 wild-type at 37uC( p .0.05) and plaques which were
slightly smaller than the wild-type at 33uC( p ,0.001, Figure 1A
and 1B).
Table 1. Amino acids at PB2 positions 627 and 701 of viruses
used in this study.
Residue 627 of PB2 Residue 701 of PB2
rPan99 wild type K D
rPan99 627E E D
rPan99 627E 701N E N
rVN1203 wild type K D
rVN1203 627E E D
rVN1203 627E 701N E N
doi:10.1371/journal.ppat.1000252.t001
Author Summary
To cause a pandemic, an influenza virus must transmit
efficiently from human to human. The viral factors that
enable person-to-person spread of influenza viruses
remain elusive. Using the guinea pig, an animal which
we have previously shown to model the human transmis-
sion of influenza, we have identified two specific residues
in the viral polymerase, at PB2 positions 627 and 701, that
can contribute to efficient transmission. Interestingly, the
two adaptive mutations examined act independently to
achieve the same phenotype. Furthermore, these residues
impact the transmission of both H3N2 and H5N1 subtype
influenza viruses in the context of a mammalian host. The
common importance of these amino acids to two diverse
virus strains—the human-adapted H3N2 and the more
avian-like H5N1—indicates that their mutation may be a
common route to the development of a transmission-
competent virus. These findings suggest one feature that
contributes to the making of a pandemic influenza virus.
PB2 627K and 701N Contribute to Transmission
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rVN1203 (PB2 627K) virus produced larger plaques than either
the 627E or the 627E 701N mutant viruses (Figure 1C and 1D).
The plaque size of all three viruses was reduced at 33uC compared
to 37uC, but the reduction was most striking for the rVN1203 virus
encoding PB2 627E. This virus produced pinpoint plaques at
33uC, indicating a significant impairment in plaque formation at
the lower temperature. At 37uC the average diameter of plaques
formed by rVN1203 627E was approximately 2.0-fold smaller
than the wild-type (p,0.001); while at 33uC the plaques of
rVN1203 627E were approximately 3.4-fold smaller than
rVN1203 wild-type (p,0.001). Thus, rVN1203 627E was
attenuated under both growth conditions, but attenuation was
greater at 33uC. Similar to the rPan99 viruses, the rVN1203 virus
encoding PB2 627E 701N produced plaques which were closer in
size to the rVN1203 wild-type virus (1.2-fold reduced at 33uC,
p,0.01, and 1.2-fold reduced at 37uC, p,0.001; Figure 1C and
1D).
Multicycle growth of recombinant wild-type and PB2
mutant viruses in MDCK cells
To test whether the PB2 627E mutation results in a cold
sensitive growth phenotype in the Pan99 background, the multi-
cycle growth of the rPan99 based viruses in MDCK cells was
compared at 33uC and 37uC. Cells were inoculated at low
multiplicity (0.01 PFU/cell) and supernatant was sampled at 3, 10,
24, 48, and 72 h p.i. As shown in Figure 2, all three rPan99 based
viruses grew to higher titers when incubated at 33uC than at 37uC.
This result probably reflects the fact that Pan99 virus is highly
adapted to growth in the upper respiratory tract of humans. At
either temperature, the wild-type virus was found to yield the
highest titers. The PB2 627E mutant was attenuated relative to the
wild-type virus by greater than 10-fold at both 37uC and 33uC and
at all time points except the first. Thus, in the Pan99 background,
PB2 627E is an attenuating mutation, but does not appear to result
in cold-sensitivity as seen in avian influenza viruses [6]. This lack
of cold-sensitivity is most likely due to the presence of multiple
Figure 1. Plaque phenotypes of wild-type, PB2 627E and PB2 627E 701N viruses at 33uC and 37uC. Plaque assays were performed on
MDCK cells incubated at 33uCo r3 7 uC, as indicated at the left of the figure, and immunostained with virus-specific antibody. (A) Plaque phenotypes of
rPan99 WT and PB2 mutant viruses. (B) Average plaque diameter for each rPan99 virus is plotted at 33uC and 37uC. (C) Plaque phenotypes of rVN1203
WT and PB2 mutant viruses. (D) Average plaque diameter for each rVN1203 virus is plotted at 33uC and 37uC. Plaque assays of rPan99 viruses and
rVN1203 viruses were performed at different times. Error bars indicate standard deviation. * indicates p,0.01 and ** indicates p,0.001, as
determined by t-test of plaque diameter values.
doi:10.1371/journal.ppat.1000252.g001
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adapted virus. At 33uC and 37uC, the rPan99 627E 701N virus
grew to intermediate titers relative to the rPan99 and rPan99 627E
viruses. These results suggest that, in MDCK cell culture, the
attenuated phenotype of a K627E mutant is partially rescued by
the D701N mutation.
A similar experiment was then performed with the rVN1203-
based viruses. MDCK cells were inoculated at an MOI of 0.01
with rVN1203, rVN1203 627E or rVN1203 627E 701N viruses
and supernatant was sampled at 2, 24, 48, and 72 h.p.i. As shown
in Figure 2, there were no marked differences in the viral yields
attained at either temperature. All three viruses grew to high titers
by 24 h.p.i., although, at 33uC, the 627E mutant virus grew to 8.5-
fold lower titers than the wild-type.
Growth of rPan99, rPan99 627E, and rPan99 627E 701N in
the upper and lower respiratory tracts of guinea pigs
To test whether the phenotypes of rPan99 627E and rPan99
627E 701N seen in vitro are also manifested in vivo, we evaluated
the titers of these viruses in the nasal passages and lungs of infected
guinea pigs. Growth in the upper respiratory tract was assessed by
collecting nasal lavage from intranasally inoculated animals on
days 2 and 4 p.i. As shown in Figure 3A, rPan99 wild-type virus
grew to a titer of 10
7 PFU/mL at 2 d p.i. At this time point, the
rPan99 627E virus produced a 30-fold lower titer. The kinetics of
growth of the 627E mutant virus were delayed relative to the wild-
type, with a higher titer (of 2.3610
6 PFU/mL) being reached at
4 d than at 2 d p.i. The rPan99 627E 701N double mutant
exhibited an intermediate phenotype: titers on day 2 p.i. were only
Figure 2. Growth kinetics of wild-type, PB2 627E and PB2 627E 701N viruses in MDCK cells incubated at 37uC and 33uC. (A) and (B)
show the results from rPan99-based viruses, while (C) and (D) show the results from rVN1203-based viruses. Titers of the wild-type viruses are shown
with squares and solid lines; titers of PB2 627E mutants are shown with triangles and long dashed lines; and titers of PB2 627E 701N viruses are shown
with circles and short dashed lines. The MOI of infection in all cases was 0.01 PFU/cell. ** all three viruses are significantly different from each other
(p,0.05, Student’s t-test). * the titers of both mutants are significantly different from those of the wild-type (p,0.05, Student’s t-test). # the titers of
the 627E mutant are significantly different from those of both the wild-type and the 627E 701N viruses. { the titers of the 627E 701N double mutant
are significantly different from those of both the wild-type and the 627E single mutant viruses.
doi:10.1371/journal.ppat.1000252.g002
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627E) relative to rPan99 wild-type. Thus, moderate differences in
viral titers achieved in the upper respiratory tract were observed
between the three Pan99-based viruses, but this difference was
observed only at day 2, and not day 4, post-inoculation.
Growth in the lower respiratory tract was assessed by titrating
virus harvested from homogenates of guinea pig lung collected on
days 2 and 4 p.i. Growth in the lungs was affected to a lesser extent
by the K627E and D701N mutations than growth in the nasal
passages. Clearance of the wild-type virus from the lungs appeared
to be initiated more quickly than for the two mutant viruses;
nevertheless, average titers of all three viruses were comparable on
day 2 p.i. (2.4–7610
4 PFU/g) and day 4 p.i. (2.2–12610
4 PFU/g)
(Figure 3B).
Figure 3. Growth kinetics of rPan99 wild-type, rPan99 627E and rPan99 627E 701N viruses in the upper and lower respiratory tracts
of guinea pigs. (A) Viral titers in nasal wash samples of infected guinea pigs are plotted on days 2 and 4 p.i. On day 2 p.i., titers of the wild-type virus
were significantly different from rPan99 627E (p=0.0020) and from rPan99 627E 701N (p=0.0057). On day 4 p.i., titers of the wild-type virus were not
significantly different from those of either PB2 mutant virus (p$0.03). (B) Titers of virus recovered from the supernatant of homogenized lung tissue
at 2 d and 4 d p.i. Virus in three tissue samples from each of two animals was quantified; titers from one guinea pig are shown with open squares and
titers from the second guinea pig are shown with closed diamonds. Titers of the wild-type virus were not significantly different from rPan99 627E
(p=0.39 on day 2 and p=0.011 on day 4) or from rPan99 627E 701N (p=0.067 on day 2 and p=0.025 on day 4). All p-values were determined by
Student’s t-test. * indicates a significant difference relative to the wild-type, with p,0.01 as determined by Student’s t-test. The mean and standard
deviation for each data set are shown above the corresponding data points.
doi:10.1371/journal.ppat.1000252.g003
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627E 701N
We used the guinea pig model to characterize the transmission
phenotypes of rPan99 wild-type, rPan99 627E and rPan99 627E
701N viruses. Two (rPan99 wild-type) or three (rPan99 627E and
rPan99 627E 701N) independent experiments were performed
with each virus, in which we assessed the rate of spread by the
aerosol (large or small respiratory droplet) route. Each experiment
involved eight guinea pigs: four infected intranasally with 1000
PFU of the appropriate virus, and four exposed animals. The
rPan99 wild-type virus transmitted to all eight exposed guinea pigs
(Figure 4A), as expected based on previous results with the non-
recombinant Pan99 virus [7,22]. The PB2 mutant virus, rPan99
627E, transmitted less efficiently, with just six of twelve exposed
animals contracting infection, and with slower kinetics relative to
the wild-type (Figure 4B). Partial rescue of the transmission defect
was observed when the PB2 D701N change was also present:
rPan99 627E 701N virus transmitted to ten of twelve exposed
guinea pigs (Figure 4C). Transmission to contact animals, as
measured by isolation of virus in nasal washings, was verified by
hemagglutination inhibition assay of paired sera for each guinea
pig (Table 2). To confirm that the mutant viruses had not reverted
to the wild-type PB2 sequence prior to transmission, the PB2 genes
of isolates from two exposed guinea pigs were sequenced for each
virus. All transmitted viruses examined retained the introduced
mutations. Thus, in the background of a human H3N2 isolate,
mutation of PB2 residue 627 from K to E decreases the efficiency
of transmission, while the introduction of D701N alongside
K627E results in a phenotype more similar to that of the wild-
type virus.
Contact transmission of rVN1203, rVN1203 627E, and
rVN1203 627E 701N
To test whether the introduction of K627E or K627E D701N
mutations would also alter the transmissibility of the rVN1203
virus, contact transmission experiments were performed in guinea
pigs. Each experiment involved eight guinea pigs: four infected
intranasally with 10
4 PFU of the appropriate virus, and four
exposed animals. In this case, each exposed guinea pig was placed
in direct contact with an inoculated animal by placing them in the
same cage at 24 h p.i. It is important to note that a different
experimental set up (aerosol versus contact transmission experi-
ments), including a different inoculum dose, was used for the
experiments with the rVN1203-based viruses, relative to the
experiments with the rPan99-based viruses. Thus, the results
shown in Figure 4 should not be compared directly to those
presented in Figure 5. As shown in Figure 5A, the rVN1203 wild-
type virus transmitted rapidly to three of four contact guinea pigs.
In contrast, the rVN1203 PB2 627E mutant transmitted to only
one contact animal (Figure 5B). While this result suggests that this
single amino acid change – PB2 K627E – reduces the transmission
potential of a highly pathogenic avian influenza virus in a
mammalian species (p=0.09, Student’s t-test), an increased
number of replicates would be required to prove a statistically
significant reduction in transmission. Furthermore, due to the
space constraints and high cost of housing animals under BSL3-
enhanced containment, we did not retain guinea pigs infected with
VN1203 virus for the three weeks required to obtain convalescent
sera for HI assays in order to assess transmission to contact animals
by seroconversion.
The PB2 gene of the transmitted virus was subjected to RT
PCR and sequencing and the introduced mutation, K627E, was
found to be maintained. In contrast, virus isolated from three of
the inoculated animals late in the course of infection (day 6 p.i.)
exhibited large plaque phenotypes, suggesting reversion had
occurred. The sequencing of one of these isolates confirmed the
presence of lysine at PB2 627. As shown in Figure 5C, the
rVN1203 627E 701N double mutant virus spread to all four
contact guinea pigs. Although slightly more efficient (100%
compared to 75% for the wild-type virus), transmission of the
rVN1203 627E 701N double mutant virus appeared to occur with
slower kinetics than the wild-type, based on the relatively low titers
isolated from contact animals 24 h after the initiation of contact.
Taking into account the virus titers shed by the inoculated animals
and the 50% infectious doses of the wild-type and double mutant
viruses (see below and Table 3), it is unclear why the kinetics of
transmission differ. Again, sequencing of the PB2 gene of one
Figure 4. Aerosol transmission of rPan99 wild-type, rPan99 627E and rPan99 627E 701N viruses in guinea pigs. Nasal wash titers are
plotted as a function of time post-inoculation. Titers of intranasally inoculated animals are represented by dashed lines and filled squares; titerso f
exposed guinea pigs are shown with solid lines and filled triangles. (A) The cumulative results of two experiments with rPan99 wild-type virus are
shown. All four exposed guinea pigs were infected in both experiments. (B) The cumulative results of three experiments with rPan99 627E are shown.
One of four, three of four and two of four exposed guinea pigs became infected in the first, second and third experiments, respectively. (C) The
cumulative data from three experiments with rPan99 627E 701N are shown. Two of four, four of four, and four of four exposed guinea pigs became
infected in the first, second, and third experiments, respectively.
doi:10.1371/journal.ppat.1000252.g004
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experiments.
rPan99 wild-type rPan99 PB2 627E rPan99 PB2 627E 701N
Virus detection* Seroconversion** Virus detection* Seroconversion** Virus detection* Seroconversion**
Expt. 1 Inoculated 1 ++++ ++
Inoculated 2 ++++ ++
Inoculated 3 ++++ ++
Inoculated 4 ++++ ++
Exposed 1 ++22 ++
Exposed 2 ++22 ++
Exposed 3 ++++ ++
Exposed 4 ++++ ++
Expt. 2 Inoculated 1 ++++ ++
Inoculated 2 ++++ ++
Inoculated 3 ++++ ++
Inoculated 4 ++++ ++
Exposed 1 ++++ ++
Exposed 2 ++++ ++
Exposed 3 ++++ ++
Exposed 4 ++22 ++
Expt. 3 Inoculated 1 n/a
# n/a ++ ++
Inoculated 2 n/a n/a ++ ++
Inoculated 3 n/a n/a ++ ++
Inoculated 4 n/a n/a ++ ++
Exposed 1 n/a n/a 22 ++
Exposed 2 n/a n/a 22 22
Exposed 3 n/a n/a ++ ++
Exposed 4 n/a n/a 22 22
*limit of detection was 10 PFU/ml.
**seroconversion was defined as a $4-fold increase in hemagglutination-inhibition titer.
#n/a not applicable; a third experiment was not performed with rPan99 wild-type.
doi:10.1371/journal.ppat.1000252.t002
Figure 5. Contact transmission of rVN1203 wild-type, rVN1203 627E and rVN1203 627E 701N viruses in guinea pigs. Nasal wash titers
are plotted as a function of time post-inoculation. Titers of intranasally inoculated animals are represented by dashed lines and filled squares; titers of
exposed guinea pigs are shown with solid lines and filled triangles. (A) Transmission of rVN1203 wild-type virus. (B) Transmission of the rVN1203 627E
mutant. (C) Transmission of the rVN1203 627E 701N double mutant.
doi:10.1371/journal.ppat.1000252.g005
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mutations were retained. Thus, the amino acid change PB2
D701N favors the transmission of an H5N1 virus in a mammalian
host and this mutation fully compensates for the lack of a lysine at
position 627 in terms of transmission by the contact route.
Despite productive growth of all three VN1203-based viruses in
the guinea pig respiratory tract, clinical signs were not observed
following either intranasal inoculation or infection through contact
transmission. The average peak nasal wash titers (reached on day 2
p.i.) of guinea pigs intranasally inoculated with the rVN1203 wild-
type and 627E mutant viruses were similar, at approximately
2.3610
5 PFU/ml. The titers of the double mutant virus shed by
inoculated guinea pigs at day 2 p.i. were higher, at about
1.1610
6 PFU/ml. Statistical analysis indicated that only the
difference between the wild-type and double mutant virus was
significant, with a p value of 0.044 (Student’s t-test). Overall, the
data do not convincingly show that enhanced shedding from the
upper respiratory tract contributes to improved transmission of the
rVN1203 wild-type virus. In a separate experiment designed to
investigate a possible role in transmission of shedding in the feces,
we collected rectal swab samples from guinea pigs inoculated with
wild-type rVN1203 virus on days 2, 4, and 6 post-infection. No
virus was detected in these rectal swab samples, despite efficient
isolation of virus from the upper respiratory tract of the same
animals. 50%
Infectious dose of rPan99 and rVN1203-based viruses in
guinea pigs
In both the rPan99 and rVN1203 backgrounds, the identities of
PB2 residues 627 and 701 had a clear effect on transmission.
Nevertheless, contrary to our expectations, mutation of these
amino acids in the rVN1203 background did not have a striking
effect on peak viral growth in the upper respiratory tract of guinea
pigs (Figure 5). In the rPan99 background, differences in shedding
titers were seen on day 2 p.i., which may have contributed to the
transmission phenotypes observed. The effect, however, was
limited to day 2 p.i., with similar peak titers being reached by
all three viruses by day 4 p.i. (Figure 3A and Figure 4). We
therefore reasoned that the reduction in transmissibility may be
due to an effect on the recipient, as well as possibly the donor, host
in the transmission equation. In other words, we predicted that the
50% infectious dose (ID50) of the PB2 627E containing viruses
would be higher than either the wild-type or the double mutant
viruses. To test this prediction, we inoculated groups of four
guinea pigs with 10-fold serial dilutions of each of the six
recombinant viruses to determine the GPID50 in each case. The
results are summarized in Table 3. In both virus backgrounds, the
GPID50 of the wild-type and 627E 701N double mutant viruses
were found to be very similar or the same. In contrast, the rPan99
627E virus had a GPID50 of approximately 10-fold higher, and the
rVN1203 627E virus had a GPID50 of approximately 7-fold
higher than the corresponding wild-type viruses. Although the
differences are marginal, it is possible that decreased infectivity
contributes to the inefficient transmission phenotypes of both
627E-containing viruses.
Discussion
In the context of an influenza virus which is well adapted to the
human host, rPan99, and an avian-like influenza virus isolated
from a human host, rVN1203, we have shown that polymor-
phisms at residues 627 and 701 of PB2 influence transmission
among guinea pigs. In addition, we have tested the hypothesis
proffered by de Jong et al. [1] that, with respect to adaptation of an
avian virus to a mammalian host, D701N can functionally replace
E627K. We found that, when PB2 627 is a glutamic acid residue,
the D701N mutation not only improves viral growth in
mammalian cells, but enhances transmission between guinea pigs.
Using minigenome systems and infected cell cultures, the
introduction of the E627K mutation into an avian PB2 gene has
previously been shown to increase polymerase activity and viral
growth at 33uC [6,10]. With the mutation of the wild-type K627
to E in the rVN1203 background, we saw a marked reduction in
plaque size at both 33uC and 37uC. The degree to which the
plaque size decreased relative to the rVN1203 wild-type virus was
greater at 33uC, however, as would be expected based on earlier
reports. In the rPan99 background, the reduction in plaque size
observed with the K627E mutation was again seen at both
temperatures and was more subtle than for rVN1203. The
observation that the fully human-adapted virus rPan99 was better
able to tolerate the PB2 K627E mutation and maintain plaque
formation at 33uC than the more avian-like rVN1203 virus may
indicate that Pan99 has developed degenerate mechanisms to
permit growth at the lower temperature of 33uC.
The in vivo growth of the rPan99 627E virus was impaired
relative to the wild-type, but only early (day 2) after infection.
Although improved growth in the upper respiratory tract early
after infection may act to increase the efficiency of transmission,
the fact that – at 4 d p.i. – the rPan99 627E and rPan99 627E
701N mutant viruses reach similar peak titers to the wild-type may
argue against this as a mechanism for the improved transmission
of the wild-type virus. In addition, contrary to recent findings in
mice [12], we did not observe marked differences in the viral titers
reached by rVN1203 wild-type, rVN1203 627E and rVN1203
627E 701N viruses in the upper respiratory tract of guinea pigs.
We did, however, see a clear effect of the PB2 mutations on
transmission in the rVN1203 background, as well as in the rPan99
background. We hypothesized that the observed transmission
phenotypes might arise from differences in infectivity. Determi-
nation of the GPID50 values of the three rVN1203- and the three
rPan99-based viruses did reveal that higher doses of the 627E
mutant viruses are required to productively infect guinea pigs.
Although suggestive, the differences observed (approximately 7-
fold for rVN1203 and 10-fold for rPan99) may be within the range
of error of the GPID50 assay. Thus, the mechanism underlying the
decreased transmission efficiencies of rVN1203 PB2 627E and
rPan99 PB2 627E viruses relative to the corresponding wild-type
and double mutant viruses remains uncertain. Our data suggest
that reduced viral growth in the nasal passages or decreased
infectivity may play a role, but do not allow us to draw firm
conclusions on this point. One additional possibility is that, despite
reaching similar peak titers in nasal lavage, the 627E mutant
viruses are not shed into the air as efficiently as the wild-type and
double mutant viruses.
For all three rVN1203 viruses, the viral growth kinetics
observed in inoculated animals were markedly different from
Table 3. Guinea pig 50% infectious dose of wild-type and
PB2 mutant viruses.
rWild-type* PB2 627E* PB2 627E 701N*
Pan99 background 24 215 22
VN1203 background 3 22 3
*GPID50 values are shown in units of PFU/guinea pig.
doi:10.1371/journal.ppat.1000252.t003
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human-adapted influenza viruses in guinea pigs [7,8,22], but
probably reflects a dose-dependent growth phenotype of rVN1203
in this host.
In terms of viral growth in vitro and in vivo as well as transmission
between guinea pigs, the introduction of N at position 701 was
found to at least partially reverse the phenotype of the K627E
mutant viruses in both virus backgrounds tested. Further support
for the idea that 701N can compensate for a lack of 627K in
mammalian hosts is found in the published sequences of swine
influenza PB2 genes. Among the avian-like H3N2 viruses
circulating in swine, European isolates for which sequences are
available in Genbank carry 627E with 701N, while Asian isolates
predominantly carry 627K with 701D. Although the number of
transmission events is low, it may also be of note that three swine
influenza viruses isolated from humans in Asia possessed PB2
627E and 701N [23,24].
In wild birds, H5N1 viruses carrying PB2 627K arose during the
Qinghai Lake outbreak in 2005; descendants of these viruses
retaining possession of 627K continue to circulate among wild
waterfowl [25]. Furthermore, the presence of PB2 627K or 701N
has been reported in multiple human isolates of H5N1 influenza
viruses [1,17,18]. Despite the relatively high incidence of these
mammalian-adaptive mutations in human H5N1 isolates, sustained
human-to-human spread has not been observed. Thus, although
our data show that PB2 627K or 701N is necessary for optimal
transmission of either human- or avian-adapted viruses between
guinea pigs, these mutations are not sufficient to support human-to-
human spread of H5N1 influenza. Indeed, studies in the ferret
model indicate that transmissibility is a complex, multigenic trait
[2,5]. The appropriate receptor specificity is most likely required
[4,26]; we have shown that the PB2 protein plays a role; and other
viral factors most likely contribute to the transmission phenotype.
We have identified PB2 627K and 701N as determinants of
transmission between mammals. The observation that these
residues contribute to the transmission of both H3N2 and H5N1
influenza viruses between mammals suggests that adaptations in
the PB2 protein may be a prerequisite of transmission common to
all influenza A subtypes. The identification of the additional viral
factors necessary for—and ultimately the set of traits sufficient to
support—human-to-human spread will greatly improve our
understanding of how a pandemic strain arises.
Materials and Methods
Cells
Madin Darby canine kidney (MDCK) cells were maintained in
minimum essential medium (Gibco) supplemented with 10% fetal
bovine serum, 100 units/mL of penicillin, and 100 mg/mL of
streptomycin. 293T cells were maintained in Dulbecco’s minimum
essential medium (Gibco) supplemented with 10% fetal bovine
serum.
Rescue of recombinant viruses
Recombinant Pan99 and VN1203 viruses were rescued
according to previously reported protocols, with minor modifica-
tions [27,28]. Briefly, 8 pPOL1-based vRNA expression plasmids
and 7 pCAGGS-based support plasmids (for the expression of
NS1, NA, NP, HA, PA, PB1 and PB2) were used to transfect 293T
cells. At 24 h post-transfection, growth medium was replaced with
serum-free medium containing 1 mg/mL TPCK-treated trypsin
(Sigma) and MDCK cells were added to the culture. At 72 h post-
transfection, rescue supernatant was subjected to plaque assay on
MDCK cells in order to obtain clonal isolates. Rescued viruses
were propagated in 10 d old embryonated hens’ eggs (Pan99-
based) or MDCK cells (VN1203-based) at 37uC. Genotypes of
wild-type viruses were verified by RT-PCR and partial sequencing
of each of the eight segments. For the rescue of mutant viruses,
site-directed mutagenesis was used to introduce the required
mutations into the pPol1Pan99-PB2 or pPol1VN1203-PB2
plasmids using the QuikChange II Site Directed Mutagenesis kit
(Stratagene). Rescue protocols were as for the wild-type viruses.
Genotypes of the mutant viruses were confirmed through RT-
PCR and sequencing of the respective PB2 segments. The
presence of a multibasic cleavage site in the HA of rVN1203
wild-type and mutant viruses was confirmed by verifying their
ability to form plaques in the absence of trypsin (data not shown).
Viral growth in MDCK cells
Characterization of plaque phenotypes on MDCK cells was
performed as described previously [29]. All work with VN1203-
based viruses was performed in a USDA and CDC-approved
biosafety level 3+ containment laboratory in accordance with
institutional biosafety requirements. Polyclonal rabbit anti-A/
Puerto Rico/8/34 was used as the primary antibody, and
Amersham ECL
TM-HRP linked anti-rabbit was used as the
secondary antibody for immunostaining.
To examine multi-step growth, MDCK cells were infected at a
multiplicity of 0.01 PFU/cell. Following a 45 min incubation,
inoculum was removed and monolayers were washed with PBS.
Dishes were then incubated at 33uCo r3 7 uC, as indicated, and
samples of growth medium collected at 3, 10, 24, 48 and 72 h p.i
(for rPan99-based viruses) or at 2, 24, 48, and 72 h.p.i. (for
rVN1203-based viruses). Titers were determined by plaque assay
on MDCK cells.
Animals
Female Hartley strain guinea pigs weighing 300–350 g were
obtained from Charles River Laboratories Inc. (Wilmington, MA).
Animals were allowed free access to food and water and kept on a
12 h light/dark cycle. Guinea pigs were anesthetized for the
collection of blood and of nasal wash samples, using a mixture of
ketamine (30 mg/kg) and xylazine (2 mg/kg), administered
intramuscularly. All procedures were performed in accordance
with the Institutional Animal Care and Use Committee guidelines.
During guinea pig transmission experiments strict measures were
followed to prevent aberrant cross-contamination between cages:
exposed animals were handled before inoculated animals, gloves
were changed between cages, and work surfaces were sanitized
between guinea pigs.
Viral growth in guinea pig respiratory tract
Three groups of four guinea pigs were inoculated with 1000
PFU in a 300 ml volume intranasally: group 1 received rPan99,
group 2 received rPan99 PB2 627E, and group 3 received rPan99
PB2 627E 701N. At 2 d p.i., nasal washings were collected from all
12 guinea pigs. Six guinea pigs were then sacrificed for the
collection of lung tissue. At 4 d p.i., nasal washes were collected
from the remaining 6 animals; these 6 guinea pigs were then
sacrificed and the lungs removed. As described previously [22],
nasal washing was performed by instilling 1 mL PBS-BA-PS (PBS
supplemented with 0.3% bovine serum albumin, 100 units/mL of
penicillin, and 100 mg/mL of streptomycin) into the nostrils and
allowing it to drain onto a Petri dish. Samples were collected into
1.5 ml tubes and centrifuged for 5 min at 20006g and 4uC;
supernatants were stored at 280uC prior to analysis by plaque
assay. For the collection of lung tissue, animals were killed through
exposure to CO2 gas. After the lungs were removed, three lobes
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Approximately 300 mg of each lobe was then transferred to 4 ml
cold PBS-BA-PS. Thus, three samples were taken from each
animal. Extracted lung tissue was weighed, homogenized in PBS-
BA-PS and centrifuged at 12 0006g and 4uC for 10 min to pellet
debris. Immediately after preparation, supernatants were serially
diluted and subjected to plaque assay.
Data in Figure 3A represent the nasal wash titers on days 2 and
4 post-infection for all animals inoculated intranasally with the
indicated viruses. This data includes titers derived from inoculated
animals used in aerosol transmission experiments as well as the 12
inoculated animals used to assess viral growth in the upper and
lower respiratory tracts.
Aerosol transmission experiments
As in our previous publications, the term ‘‘aerosol’’ is used
herein to describe respiratory droplets of all sizes.
Aerosol transmission experiments—performed with rPan99 and
Pan99-derived mutants—were carried out as described previously
[7]. Each experiment involved eight guinea pigs; the data shown in
Figure 4 represent cumulative results from two independent
experiments for rPan99 wild-type, and three independent experi-
ments for the two rPan99 PB2 mutant viruses. Briefly, the procedure
was as follows. On day zero, four of the eight guinea pigs were
inoculated intranasally with 1000 PFU of virus. At 24 h p.i., each of
the eight guinea pigs was transferred to a ‘‘transmission cage’’ and
then placed into an environmental chamber (Caron model 6030) set
to20%relativehumidityand20uC.Eachinfectedanimalwaspaired
o nas h e l fw i t han a ı ¨ve animal; in this arrangement, no contact
between the guinea pigs is possible. The animals were housed in this
way for seven days, after which they were removed from the
chamber and separated. Nasal wash samples were collected from
anesthetized guinea pigs on days 2, 4, 6, 8, and 10 p.i. by instilling
1 mL of PBS-BA-PS into the nostrils and collecting the wash in a
Petri dish. Samples were stored at 280uC prior to analysis. Titers in
nasalwashsamplesweredeterminedbyplaqueassayof10-foldserial
dilutions on MDCK cells.
Contact transmission experiments
Contact transmission experiments were performed with
rVN1203 wild-type and rVN1203-derived PB2 mutant viruses.
This work was carried out in a USDA and CDC-approved
biosafety level 3+ containment laboratory in accordance with
institutional biosafety requirements. For each virus, four of eight
guinea pigs were inoculated intranasally with 10
4 PFU. At 24 h
p.i., each infected animal was placed in the same cage with one
naı ¨ve animal, and animals were co-housed in this way for a total of
seven days. Nasal washes were collected from all guinea pigs on
days 2, 4, 6 and 8 p.i. Samples were stored at 280uC prior to
analysis by plaque assay. Animals were euthanized through
intraperitoneal injection of 100 mg/kg sodium pentobarbital
(Nembutal; Ovation Pharmaceuticals, Inc.) on day 8 p.i. These
experiments were performed under ambient conditions (19–22uC
and 30–70% relative humidity).
Determination of guinea pig 50% infectious dose
Groups of four guinea pigs were inoculated intranasally with
ten-fold serial dilutions of each virus stock. At 2 d.p.i. nasal
washings were collected from all guinea pigs. The nasal wash
samples were analyzed by plaque assay on MDCK cells to
determine which guinea pigs were infected. The GPID50 was then
calculated by the method of Reed and Muench [30] and expressed
in PFU per guinea pig.
Accession numbers
PB2 segment of A/Panama/2007/99: Genbank accession
number DQ487334.
PB2 segment of A/Viet Nam/1203/04: Genbank accession
number AY651719.
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